Aug. 14 at 11:32 AM
$TNYA – Entry
$0.60–
$0.65 · Aug 6 2025: Phase 3 DSMB greenlight, cash runway to mid-2026.
$DCGO – Entry
$0.83–
$0.88 · Aug 7 2025: Q2 beat, guidance reaffirmed,
$128.7M cash.
$NXTT – Entry
$0.25–
$0.30 · Aug 11 2025: 80% profit dividend policy,
$312M Q2 net income.
$WDH – Entry
$0.80–
$0.85 · Jun 5 2025: Q1 net profit +34.2% YoY, 13th straight profitable quarter.
$TNYA,
$DCGO,
$NXTT, and
$WDH all show strong fundamentals or catalysts that support long-term upside—ranging from late-stage biotech progress and revenue growth to high-margin profitability with dividends and consistent multi-year earnings expansion—making them attractive holds in their respective sectors.